Released Mar 25, 2014, before the open
10-Q filed Mar 25, 2014, 176 days after period end · 0001193125-14-113186
Q3 2013 · 10-Q
Revenue$91.81M$91.81M −13.2% vs Q3 2012−6.0% vs Q2 2013
Net Income-$18.84M-$18.84M N/M vs Q3 2012N/M vs Q2 2013
EPS Diluted-$1.04-$1.04 N/M vs Q3 2012N/M vs Q2 2013
Gross Profit$66,742,000−17.5%
Operating Income-$14,101,000N/M
Operating Cash Flowderived$17,766,000+67.0%
Free Cash Flowderived$11,165,000+113.9%
Margins · derived
Gross margin72.7%−3.8 pt vs Q3 2012
Operating margin-15.4%−31.4 pt vs Q3 2012
Net margin-20.5%−24.1 pt vs Q3 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $91.81M | $105.82M | $111.51M | $138.91M |
| Net Income | -$18.84M | $3.75M | $10.08M | $8.52M |
| EPS Diluted | -$1.04 | $0.19 | $0.54 | $0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR